Glaxo (GSK), Human Genome Sciences (HGSI) win FDA approval of lupus drug Benlysta

Go back to Glaxo (GSK), Human Genome Sciences (HGSI) win FDA approval of lupus drug Benlysta
GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 52.38 +0.42 (0.81%)
Previous Close $51.96    52 Week High $45.58 
Open $51.35    52 Week Low $37.82 
Day High $52.46    P/E N/A 
Day Low $51.35    EPS $0.00 
Volume 1,334,843       

Human Genome Sciences, Inc. (NASDAQ: HGSI) Delayed: 14.24 --0 (-0%)
Previous Close $14.24    52 Week High $16.58 
Open $55.80    52 Week Low $6.51 
Day High $14.24    P/E N/A 
Day Low $14.24    EPS $-1.79 
Volume 557,147